So, by inhibiting the RTK pathway, the mediation of cellular proliferation is reduced.Dysregulation of cell proliferation is a key feature of cancer, and we can label PDCD1 as a tumor-promoting gene. The gene discussed is PDCD1; the disease is neoplasm.